Tucker Roussin is a four-year-old healthy boy. When his mother, Katie, was 20 weeks pregnant, he was diagnosed with a pericardial teratoma, an extremely rare tumor that grows on the lining surrounding the heart. The tumor was almost as large as his tiny heart, and it was growing quickly. Clinicians at the Center for Fetal Diagnosis and Treatment at Children’s Hospital of Philadelphia (CHOP) recommended an open fetal surgery to remove the tumor.
Georgia Beasley was a student-athlete at Duke when she met Sara, an 11-year-old girl, who was sitting on the bleachers at Cameron Indoor Stadium. The young girl was waiting for her father, who was late to pick her up from a Duke basketball summer camp. Beasley asked her to catch rebounds for her, and Sara happily agreed. Later, her father introduced himself as none other than Henry Friedman, MD, deputy director of the Preston Robert Tisch Brain Tumor Center at Duke.
In 2005, Fumiko Chino, MD’14, thought she had her future planned out. She was engaged to be married and was working in her dream job as an art director for a video animation company in Houston, Texas. “I got paid to watch cartoons for a living,” she says. “It was fun.”
Outside, it is a Friday afternoon in early March: cold, bright, windy. Inside- in a small room on the first floor of the Duke Clinic – it is after dinner and Count Ilyick Rostov has downed another ryumka of vodka in the bar of Moscow’s Hotel Metropol.
People diagnosed with cancer enter a period of intense treatment at a cancer center, and it can seem to their primary care physicians that they have disappeared. The patient’s overall health can suffer as a result. Duke’s new Center for Onco-Primary Care aims to change that.
Bill Hudson and L.C. Industries provided major financial support for building the new state-of-the-art Duke Eye Center building. Mr. Hudson and Duke's world-class ophthalmologists and researchers, share a passion to cure all blindness by creating the future of eye care at Duke.
Through the Regeneration Next Initiative, Duke researchers are gaining insights into how to stimulate heart muscle to regrow after injury.
Researchers at the Duke Cancer Institute are teaming up with several other institutions to develop a fluorescent dye that is injected into cancerous tumors and lights up when viewed under a special camera. This allows surgeons to see if residual cancer remains after the tumor has been removed.
Learn why Paul Rudershausen is cycling across North America to raise funds for the research of Jason Somarelli, PhD, at Duke Cancer Institute. Somarelli studies the genes that promote cancer spread in both humans and dogs.